#TRIPLE NEGATIVE BREAST CANCER PROGNOSIS SOFTWARE#

It may be used with chemotherapy medicines when your breast cancer has returned and cannot be removed by surgery or has spread (advanced TNBC), and tests positive for “PD⁠-⁠L1.”.It may be used with chemotherapy medicines as treatment before surgery and then continued alone after surgery when you have early-stage breast cancer, and are at high risk of your breast cancer coming back (high-risk early-stage triple-negative breast cancer ).a kind of cancer called triple-negative breast cancer (TNBC).Want a quick and expert briefing on the biggest news stories? Listen to our latest podcasts to find out What You Need To Know.KEYTRUDA is a prescription medicine used to treat: “We look forward to further findings to understand how this could work in practice to benefit women affected by this type of breast cancer.”

#TRIPLE NEGATIVE BREAST CANCER PROGNOSIS SOFTWARE#

“We want to leverage this change to develop AI-powered software based on our model for pathologists to use to benefit women with this hard-to-treat breast cancer.”ĭr Simon Vincent, director of research, support and influencing at Breast Cancer Now, said: “If, thanks to this research, it’s possible to provide women with more tailored treatment and care based on the likelihood of the breast cancer spreading, it could help to save lives and reduce stress and worry. “The transition from assessing tissue on glass slides under a microscope to using computers in the NHS is gathering pace. The team also found the AI model was able to make this prediction by simply analysing the immune responses in the lymph nodes, even when the breast cancer cells had not spread to the organs.Īs part of the next steps, the researchers are hoping their AI model will be tested in clinical trials.įake 'AI created' image of Pentagon explosion sparks brief panicĭr Grigoriadis added: “We’re planning to test the model further at centres across Europe to make it even more robust and precise. “We’ve taken these findings from under the microscope and translated them into a deep-learning framework to create an AI model to potentially help doctors treat and care for patients, providing them with another tool in their arsenal for helping to prevent secondary breast cancer.” One of the first places breast cancer can spread to is the lymph nodes under the arm on the same side as the cancer.ĭr Anita Grigoriadis, who led the research at the Breast Cancer Now Unit at King’s College London, said: “By demonstrating that lymph node changes can predict if triple negative breast cancer will spread, we’ve built on our growing knowledge of the important role that immune response can play in understanding a patient’s prognosis.

Lymph nodes are small, bean-shaped structures that help filter cancer cells and fight infection. In these cases, patients are likely to need more intensive treatment. Women who have inherited an altered BRCA gene, black women, and women who have not yet reached the menopause are at higher risk of triple negative breast cancer.Īround one in seven of all breast cancers in the UK are triple negative, with more than 8,000 cases a year. This type of the disease does not have any of the receptors (proteins) commonly found in breast cancer and accounts for around 25% of breast cancer deaths. Groundbreaking fingerprint test detects breast cancer with 98% accuracy

Triple negative breast cancer prognosis